Gilmour Duncan 4
4 · INTEST CORP · Filed Mar 8, 2024
Insider Transaction Report
Form 4
INTEST CORPINTT
Gilmour Duncan
CFO, Treasurer & Secretary
Transactions
- Award
Common Stock
2024-03-06+7,356→ 39,046 total - Award
Common Stock
2024-03-06+7,355→ 46,401 total - Award
Employee Stock Option (right to buy)
2024-03-06+12,724→ 12,724 totalExercise: $11.33Exp: 2034-03-05→ Common Stock (12,724 underlying)
Holdings
- 12,848
Employee Stock Option (right to buy)
Exercise: $9.76Exp: 2032-03-08→ Common Stock (12,848 underlying) - 8,104
Employee Stock Option (right to buy)
Exercise: $16.80Exp: 2031-06-13→ Common Stock (8,104 underlying) - 200(indirect: By Spouse)
Common stock
- 8,044
Employee Stock Option (right to buy)
Exercise: $16.06Exp: 2033-03-07→ Common Stock (8,044 underlying)
Footnotes (6)
- [F1]These restricted shares were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 6, 2025.
- [F2]These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 6, 2027 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 11,033.
- [F3]This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 6, 2025.
- [F4]This option vests in four equal annual installments commencing on March 8, 2024.
- [F5]This option vests in four equal annual installments commencing on March 9, 2023.
- [F6]This option vests in four equal annual installments commencing on June 14, 2022.